Veracyte concluded 2025 with a strong fourth quarter, growing total revenue by 19% to $140.6 million. The growth was primarily driven by the Decipher and Afirma tests, which saw revenue increases of 27% and 16% respectively. The company achieved a significant GAAP net income of $41.1 million and generated over $50 million in cash from operations during the quarter.
Total revenue grew 19% year-over-year to $140.6 million, with testing revenue up 21%.
Decipher revenue increased 27% to $85.6 million, while Afirma revenue grew 16% to $47.9 million.
GAAP net income reached $41.1 million, representing 29.3% of revenue, a 705% improvement over the prior year.
Adjusted EBITDA margin expanded to 30.1%, reflecting best-in-class profitability alongside strong growth.
Veracyte reiterated its 2026 revenue guidance and provided adjusted EBITDA margin expectations.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance